1. Heyman, I. A., Thompson, G. R., Schiappi, A. H., Rosenkrantz, H., Fleishman, R. W., et al.: Report MRI 6002–71–19, Contract NIH–70–2055, Dept. of HEW, PHS, NIH, NCI, Laboratory of Toxicology, 1971.
2. Kociba, R. J., Sleight, S. D.: Acute toxicologic and pathologic effects of cis-diamminedidlloroplatinum (NSC-119 875) in the male rat. Cancer Chemother. Rep. (Part 1 ) 55, 1 (1971).
3. Kociba, R. J., Sleight, S. D., Rosenberg, B.: Inhibition of dunning ascitic leukemia and Walker 256 carcinosarcoma with cis-diamminedidlloroplatinum (NSC-119 875). Cancer Chemother. Rep. (Part 1 ) 54, 5 (1970).
4. Rosenberg, B., Van Camp, L.: The successful regression of large solid sarcoma 180 tumors by platinum compounds. Cancer Res. 30, 1977 (1970).
5. Speer, R. J., Lapis, S., Ridgeway, H., Meyers, T. D., Hill, J. M.: Cis-platinumdiamminedichloride (PDD) in combination therapy of leukemia L-1210. Wadley Med. Bull. 1, 103 (1971)